Open AccessCOVID-19 infection mortality risk in Iranian patients with type 2 diabetes, hypertension and obesity
Author(s) -
Mahdi Shadnoush,
Soghra Rabizadeh,
Alireza Esteghamati,
Manouchehr Nakhjavani,
Nasrin Baiat Paridari,
Mostafa Khoshabi,
Asadollah Rajab,
Fatemeh Ghaemi
Publication year - 2022
Publication title -
eastern mediterranean health journal/eastern mediterranean health journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 47
eISSN - 1687-1634
pISSN - 1020-3397
DOI - 10.26719/emhj.21.056
Subject(s) - medicine , odds ratio , diabetes mellitus , obesity , type 2 diabetes , confidence interval , population , endocrinology , environmental health
Background: Diabetes mellitus and hypertension are highly prevalent among patients with severe COVID-19. Aims: To study the mortality risk of COVID-19 infection in patients with type 2 diabetes and additive effect of hypertension and obesity in the Iranian population. Methods: This was a cross-sectional survey of the national COVID-19 registry from the Iranian Ministry of Health. The medical status of 22 002 patients with COVID-19 between 1 March and 30 April 2020 was analysed. Results: Patients with type 2 diabetes had a higher risk of mortality with an odds ratio (OR) of 1.67 [95% confidence interval (CI): 1.53–1.82, P < 0.001]. The risk of mortality was also high in patients with diabetes and hypertension, with an odds ratio of 1.76 (95% CI: 1.56–1.99, P < 0.001). The odds ratio of the risk of mortality in patients with diabetes, hypertension and obesity was 1.87 (95% CI: 1.35–2.58, P < 0.001). Conclusion: Type 2 diabetes, hypertension and obesity each predict mortality in Iranian patients with COVID-19, and when they are present together, patients have a greater risk of mortality